the aid library

LIST OPTIONS

Filter

9008

Second WHO Model List of Essential In Vitro Diagnostics

World Health Organization WHO (2019) C_WHO

The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and monitoring of specific diseases. The List is divid... more

Download (1934)

View PDF (3262)

Cómo combatir el cólera: Presentación y manejo clínico para el brote de cólera en Haití de 2010

CDC, U.S. Department of Health and Human Services (2010) C_CDC

The document titled "Cómo combatir el cólera" (How to Combat Cholera) provides comprehensive guidelines on the clinical presentation and management of cholera, particularly in the context of the 2010 Haiti outbreak. It emphasizes the importance of rapid rehydration as a lifesaving measure, deta... more

Download (4673)

View PDF (5025)

How to Recognise and Manage Leprosy Reactions
recommended

The International Federation of Anti-Leprosy Associations (ILEP) (2002) C1

This book is for all health workers who may have to help people who have nerve damage to their eyes, hands and feet. It will help them to encourage patients to develop a lifetime habit of caring for nerve-damaged parts.

Download (337)

View PDF (445)

Estimated Burden of Serious Fungal Infections in Mozambique

Jahit S, David WD (2018) C1

With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV, patients with asthma, as well as those under intensive care. We also highlight from studies in progress of high incidences of histoplasm... more

Download (301)

View PDF (427)

Ready to Come Back: Teacher Preparedness Training Package
recommended

UN Children's Fund UNICEF (2020) C_UNICEF

The package provides practical, concise yet crucial information about the impact of COVID-19 on daily teaching practices as well as tips and suggestions to improve safety, well-being and learning, with students in face-to-face or remote settings. The package speaks directly to the teachers. It ca... more

Download (311)

View PDF (462)

The Importance of Pharmacovigilance

World Health Organization WHO (2020) C_WHO

The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug... more

Download (320)

View PDF (574)

The COVID-19 Risk Communication Package For Healthcare Facilities
recommended

World Health Organization WHO, Regional Office for Western Pacific (2020) C_WHO

In response to the COVID-19 outbreak this risk communication package for healthcare facilities provides healthcare workers (HCWs) and healthcare facility management with the information, procedures, and tools required to safely and effectively work. The package contains a series of simplified messag... more

Download (389)

View PDF (390)

A Matter of Life and Death: Tackling Violence against Health Care in Pakistan, Peru and El Salvador

International Committee of the Red Cross (ICRC) (2017) C1

Every day, health-care providers are being attacked, patients discriminated against, ambulances held up at checkpoints, hospitals bombed, medical supplies looted and entire communities cut off from critical services around the world.
Between January 2012 and December 2014, the ICRC documented n... more

Download (388)

View PDF (560)

Hypertension Control Change Package

Centers for Disease Control and Prevention (CDC) (2020) C_CDC

second edition Included more self-measured blood pressure (SMBP)-focused content with tools and resources. Showcased more tools to find patients with potentially undiagnosed HTN. Added new strategies that focus on chronic kidney disease testing and identification.

Download (254)

View PDF (238)

The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study

Khuluza, F.; Haefele-Abah, C. PLoS ONE (2019) CC

The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy... more

Download (406)

View PDF (560)

Psychosocial counselling and treatment adherence support for people affected by tuberculosis

The Union (2021) C1

The guide is suitable and can be used for the following audiences: 1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice; 2. governmental and non-governmental employers of lay and professional TB treatment ... more

Download (475)

View PDF (702)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (283)

View PDF (392)

Making Health Care Safer – Antibiotic Rx in Hospitals: Proceed with Caution

Centers for Disease Control and Prevention CDC (2019) C_CDC

Antibiotics save lives, but poor prescribing practices are putting patients at unnecessary risk for preventable allergic reactions, super-resistant infections, and deadly diarrhea. Errors in prescribing decisions also contribute to antibiotic resistance, making these drugs less likely to work in th... more

Download (213)

View PDF (402)

International Pharmaceutical Federation (FIP) - A handbook for pharmacists

Nunes da Cunha I., Autry E. et al International Pharmaceutical Federation (FIP) (2022) CC2

The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists ... more

Download (979)

View PDF (2023)

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach

World Health Organization, UNAIDS, United Nations Office on Drugs and Crime (2008)

These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.

Download (1595)

View PDF (3336)

Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries

Médecins sans Frontières MSF (2022) C2

This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child... more

Download (1363)

View PDF (3027)

Tuberculose. Guide pratique à l’usage des médecins, infirmiers, techniciens de laboratoire et auxiliaires de santé
recommended

Mèdecines sans Frontières MSF (2022) C3

Download (243)

View PDF (317)

Guidelines for the management of chronic asthma in adolescents and adults

Lalloo, U.; Wong, M.; Abdool-Gaffar, S. et al. South African Family Practice (2007) CC

Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde... more

Download (307)

View PDF (400)

WHO Worldwide country situation analysis: response to antimicrobial resistance

World Health Organization WHO (2015) C_WHO

WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga... more

Download (198)

View PDF (377)

Strengthening and adjusting public health measures throughout the COVID-19 transition phases

World Health Organization (Europe) (2020) C_WHO

24 April 2020 Policy considerations for the WHO European Region This document provides key considerations for Member States to help them to decide on the modulation of large-scale restrictive public health measures (i.e. movement restrictions and large-scale physical distancing), while at the... more

How to Recognise and Manage Leprosy Reactions recommended

Ready to Come Back: Teacher Preparedness Training Package recommended

The COVID-19 Risk Communication Package For Healthcare Facilities recommended

Tuberculose. Guide pratique à l’usage des médecins, infirmiers, techniciens de laboratoire et auxiliaires de santé recommended

How to Recognise and Manage Leprosy Reactions
recommended

Ready to Come Back: Teacher Preparedness Training Package
recommended

The COVID-19 Risk Communication Package For Healthcare Facilities
recommended

Tuberculose. Guide pratique à l’usage des médecins, infirmiers, techniciens de laboratoire et auxiliaires de santé
recommended